Scientists Find Brain Signal That May Explain Some Autism Cases

Scientists just mapped out a promising new piece of the autism puzzle, and it points to something that might actually be stoppable.

Researchers at the Hebrew University of Jerusalem discovered that nitric oxide, a tiny molecule that normally helps brain cells communicate smoothly, can sometimes act like a stuck button. When levels rise too high, it triggers a chain reaction that removes an important protective protein called TSC2 from brain cells.

Think of TSC2 as a brake pedal for cell growth and protein production. Without it, a system called mTOR goes into overdrive, potentially interfering with how neurons function and talk to each other in autism.

The team, led by Professor Haitham Amal and PhD student Shashank Ojha, examined brain samples from children with autism, including those with SHANK3 mutations and cases without a known genetic cause. They found the same pattern: reduced TSC2 levels and overactive mTOR signaling.

Here's where it gets really interesting. When scientists blocked the nitric oxide signal in lab experiments, TSC2 stayed intact and brain cell activity returned to normal ranges. They even created a modified version of TSC2 that resists the nitric oxide effect, and that worked too.

The study, published in Molecular Psychiatry, doesn't claim to explain every autism case. Autism is complex with many different causes and variations. But it does provide something researchers desperately need: a clear map of one specific chain of events they can target.

The Bright Side

This discovery matters because it identifies an exact point where scientists might intervene. Rather than trying to address autism as one overwhelming mystery, researchers now have a specific molecular step they can study and potentially influence with treatments.

The team found that when they interrupted this one chemical modification, multiple downstream effects improved. That's significant because it suggests targeting this pathway could have broader benefits for brain function.

Professor Amal emphasized that this finding opens doors for developing nitric oxide inhibitors as research tools and possible treatments. Having a precise target means future therapies could be more focused and potentially more effective than broad approaches.

Clinical samples from real children with autism showed the same molecular patterns the scientists predicted from their lab work. That connection between laboratory discoveries and human biology is exactly what moves research from theory toward practical help.

This isn't a cure or even a treatment yet, but it's a roadmap where none existed before.